[9] In March 2005, a class action lawsuit against Molex Inc. and certain of its officers and directors for artificially inflating the market price through materially false and misleading statements was announced.

[12] During this period, Molex already operated 59 manufacturing plants all over the world, posting a sustained 12% annual growth rate.

[12] Following another expansion strategy, the company started producing complex, three-dimensional electronic components for medical applications in 2011.

As a private equity investment firm, Phillips-Medisize specializes in plastic injection molding and the manufacture of medical instruments.

[17][18] Further acquisitions in pharmaceuticals included Vectura, a British maker of inhalation drug delivery devices, effective January 2025.